Publications:

Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Giovinazzo, Daniel D; Bursac, Biljana B; Sbodio, Juan I JI; Nalluru, Sumedha S; Vignane, Thibaut T; Snowman, Adele M AM; Albacarys, Lauren M LM; Sedlak, Thomas W TW; Torregrossa, Roberta R; Whiteman, Matthew M; Filipovic, Milos R MR; Snyder, Solomon H SH; Paul, Bindu D BD

Publication Date: 2021-01-26

Variant appearance in text: APP: C291S

PubMed Link: 33431651

Variant Present in the following documents:

• Main text

View BVdb publication page

Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.

Scientific Reports

Liu, Mengyu M; Dexheimer, Thomas T; Sui, Dexin D; Hovde, Stacy S; Deng, Xiexiong X; Kwok, Roland R; Bochar, Daniel A DA; Kuo, Min-Hao MH

Publication Date: 2020-10-06

Variant appearance in text: APP: C291S

PubMed Link: 33024171

Variant Present in the following documents:

• Main text
• 41598_2020_Article_73680.pdf

View BVdb publication page

Natural product-based amyloid inhibitors.

Biochemical Pharmacology

Velander, Paul P; Wu, Ling L; Henderson, Frances F; Zhang, Shijun S; Bevan, David R DR; Xu, Bin B

Publication Date: 2017-09-01

Variant appearance in text: APP: C291S

PubMed Link: 28390938

Variant Present in the following documents:

• Main text

View BVdb publication page